DSigDB Home
Search Gene
Collections
Browse Gene Sets
Download
Help

Gene Set: D4 : CTD - Epirubicin


Collection D4 : CTD
Chemical Name Epirubicin ( From PubChem : EPIRUBICIN )
FDA NPC WHO Indian Australia China Traditional
Herbal
Clinical
Trail
ApprovedNotNotApprovedNotNotNotNot
Molecular
Weight
Hydrogen Bond
Donor Count
Hydrogen Bond
Acceptor Count
cLogP Lipinski Rule
543.519 g/mol 6 12 0.7016 False(1/4)
Structure
InChI InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22-,27-/m0/s1
InChIKey AOJJSUZBOXZQNB-VTZDEGQISA-N
Links

Gene (28 / 79)


⊖ Less

Source Type Unit Value Gene PMID Assay Other
CTDdecreases(reaction)ABCB1
D015251
CTDincreases(expression)ABCB1
D015251
CTDaffects(cotreatment)ABCB1
D015251
CTDaffects(response to substance)ABCB1
D015251
CTDincreases(expression)ABCB1
D015251
CTDdecreases(reaction)ABCB1
D015251
CTDincreases(expression)ABCB1
D015251
CTDdecreases(reaction)ABCC1
D015251
CTDincreases(expression)ABCC1
D015251
CTDaffects(cotreatment)ABCC1
D015251
CTDaffects(response to substance)ABCC1
D015251
CTDdecreases(response to substance)ABCC1
D015251
CTDincreases(expression)ABCC1
D015251
CTDdecreases(reaction)ABCC1
D015251
CTDincreases(expression)ABCC1
D015251
CTDdecreases(reaction)ABCC2
D015251
CTDincreases(expression)ABCC2
D015251
CTDincreases(expression)ABCC2
D015251
CTDdecreases(reaction)ABCC2
D015251
CTDincreases(expression)ABCC2
D015251
CTDaffects(cotreatment)ABCG2
D015251
CTDaffects(response to substance)ABCG2
D015251
CTDdecreases(response to substance)ABCG2
D015251
CTDincreases(expression)BAX
D015251
CTDincreases(reaction)BAX
D015251
CTDincreases(expression)BAX
D015251
CTDincreases(expression)BAX
D015251
CTDincreases(reaction)BAX
D015251
CTDincreases(expression)BCL2
D015251
CTDdecreases(response to substance)BIRC5
D015251
CTDdecreases(response to substance)BIRC6
D015251
CTDincreases(expression)CASP3
D015251
CTDincreases(reaction)CASP3
D015251
CTDincreases(activity)CASP3
D015251
CTDincreases(activity)CASP3
D015251
CTDincreases(reaction)CASP3
D015251
CTDincreases(expression)CASP3
D015251
CTDaffects(localization)CASP3
D015251
CTDincreases(activity)CASP3
D015251
CTDincreases(expression)CASP3
D015251
CTDincreases(activity)CASP8
D015251
CTDincreases(reaction)CASP8
D015251
CTDincreases(expression)CASP8
D015251
CTDincreases(expression)CASP9
D015251
CTDincreases(reaction)CASP9
D015251
CTDincreases(activity)CASP9
D015251
CTDincreases(activity)CASP9
D015251
CTDincreases(reaction)CASP9
D015251
CTDincreases(expression)CASP9
D015251
CTDincreases(expression)CASP9
D015251
CTDaffects(cotreatment)DPYD
D015251
CTDaffects(response to substance)DPYD
D015251
CTDaffects(cotreatment)EGFR
D015251
CTDaffects(response to substance)EGFR
D015251
CTDaffects(cotreatment)ERBB2
D015251
CTDaffects(response to substance)ERBB2
D015251
CTDaffects(cotreatment)ERBB2
D015251
CTDaffects(response to substance)ERBB2
D015251
CTDaffects(cotreatment)ERBB3
D015251
CTDaffects(response to substance)ERBB3
D015251
CTDincreases(expression)FKBPL
D015251
CTDincreases(expression)IL6
D015251
CTDincreases(expression)IL6R
D015251
CTDincreases(expression)MIR302B
D015251
CTDincreases(response to substance)MIR302B
D015251
CTDincreases(expression)NPPA
D015251
CTDincreases(response to substance)PHLDA2
D015251
CTDaffects(mutagenesis)PML
D015251
CTDaffects(mutagenesis)RARA
D015251
CTDincreases(response to substance)S100P
D015251
CTDaffects(response to substance)SOD2
D015251
CTDaffects(cotreatment)TOP2A
D015251
CTDaffects(response to substance)TOP2A
D015251
CTDaffects(cotreatment)TOP2A
D015251
CTDaffects(response to substance)TOP2A
D015251
CTDincreases(expression)TP53
D015251
CTDincreases(reaction)TP53
D015251
CTDaffects(cotreatment)TYMP
D015251
CTDincreases(expression)TYMP
D015251
Download gene sets gmt, text, Detailed text
Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA

* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).